{"id":"prednisolone-acetate-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Elevated intraocular pressure"},{"rate":null,"effect":"Posterior subcapsular cataract formation"},{"rate":null,"effect":"Local irritation or stinging"},{"rate":null,"effect":"Delayed corneal wound healing"},{"rate":null,"effect":"Secondary ocular infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a glucocorticoid, prednisolone acetate binds to cytoplasmic glucocorticoid receptors, translocates to the nucleus, and modulates gene expression to decrease inflammatory mediator synthesis and immune cell infiltration. When applied topically as eye drops, it achieves high local concentration in ocular tissues while minimizing systemic absorption, making it effective for treating anterior segment inflammation.","oneSentence":"Prednisolone acetate is a corticosteroid that suppresses local inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:03:48.985Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammation and pain following ocular surgery"},{"name":"Allergic conjunctivitis"},{"name":"Anterior uveitis"},{"name":"Corneal injury"},{"name":"Steroid-responsive inflammatory conditions of the anterior segment"}]},"trialDetails":[{"nctId":"NCT07496060","phase":"PHASE4","title":"Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-08-10","conditions":"Anterior Chamber Granulomatous Uveitis","enrollment":66},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT07291089","phase":"PHASE4","title":"Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery","status":"COMPLETED","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-02-23","conditions":"Age Related Cataract, Pain Management During Cataract Surgery","enrollment":126},{"nctId":"NCT05626478","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2023-06-01","conditions":"Corneal Edema, Corneal Defect, Anterior Chamber Inflammation","enrollment":50},{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT06765980","phase":"PHASE1, PHASE2","title":"A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration","status":"RECRUITING","sponsor":"Kriya Therapeutics, Inc.","startDate":"2025-05-28","conditions":"Geographic Atrophy Secondary to Age-related Macular Degeneration","enrollment":62},{"nctId":"NCT03933631","phase":"PHASE3","title":"Pilocarpine Use After Kahook Goniotomy","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2019-05-01","conditions":"Glaucoma","enrollment":142},{"nctId":"NCT07136805","phase":"PHASE3","title":"A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis","status":"NOT_YET_RECRUITING","sponsor":"VivaVision Biotech, Inc","startDate":"2025-10-01","conditions":"Non-infectious Anterior Uveitis","enrollment":152},{"nctId":"NCT05620901","phase":"EARLY_PHASE1","title":"DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia","status":"COMPLETED","sponsor":"Lejla Vajzovic, MD, FASRS","startDate":"2023-02-01","conditions":"Vitreoretinopathy, Coats' Disease, Exudative Retinopathy","enrollment":16},{"nctId":"NCT05023304","phase":"PHASE4","title":"In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2021-08-23","conditions":"Cataract","enrollment":30},{"nctId":"NCT05157113","phase":"PHASE4","title":"Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-05-31","conditions":"Cataract, Surgery, Compliance, Patient","enrollment":70},{"nctId":"NCT05331664","phase":"PHASE4","title":"Dropless Pars Plana Vitrectomy Study","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2022-07-25","conditions":"Rhegmatogenous Retinal Detachment","enrollment":168},{"nctId":"NCT06474416","phase":"PHASE1","title":"A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2023-09-04","conditions":"Herpes Simplex Virus Type I Stromal Keratitis","enrollment":16},{"nctId":"NCT06474442","phase":"PHASE2","title":"A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis","status":"RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2025-04-28","conditions":"Herpes Simplex Virus Type I Stromal Keratitis","enrollment":40},{"nctId":"NCT06679153","phase":"PHASE2","title":"A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis","status":"COMPLETED","sponsor":"VivaVision Biotech, Inc","startDate":"2023-11-27","conditions":"Anterior Uveitis","enrollment":89},{"nctId":"NCT06681688","phase":"PHASE1, PHASE2","title":"Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC","status":"RECRUITING","sponsor":"Inder Paul Singh, M.D.","startDate":"2024-07-10","conditions":"Cataract","enrollment":94},{"nctId":"NCT05724446","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population","status":"RECRUITING","sponsor":"Salvat","startDate":"2022-12-12","conditions":"Cataracts Infantile","enrollment":60},{"nctId":"NCT06614348","phase":"PHASE2","title":"Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-10-08","conditions":"Age Related Cataract, Pain Management During Cataract Surgery","enrollment":70},{"nctId":"NCT05720715","phase":"PHASE4","title":"Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2022-01-01","conditions":"Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis","enrollment":30},{"nctId":"NCT04396990","phase":"PHASE4","title":"The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2020-06-08","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT04539548","phase":"PHASE3","title":"A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract","status":"COMPLETED","sponsor":"Ocular Therapeutix, Inc.","startDate":"2020-09-04","conditions":"Cataract","enrollment":65},{"nctId":"NCT03920007","phase":"PHASE1, PHASE2","title":"Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D","status":"ACTIVE_NOT_RECRUITING","sponsor":"Atsena Therapeutics Inc.","startDate":"2019-09-12","conditions":"Leber Congenital Amaurosis, LCA, LCA1","enrollment":15},{"nctId":"NCT04200651","phase":"PHASE4","title":"Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery","status":"TERMINATED","sponsor":"The New York Eye Surgery Center","startDate":"2020-01-13","conditions":"Glaucoma, Cataract","enrollment":25},{"nctId":"NCT04168112","phase":"PHASE4","title":"Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study","status":"COMPLETED","sponsor":"Sight Medical Doctors PLLC","startDate":"2020-02-12","conditions":"Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain","enrollment":20},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT04184999","phase":"PHASE4","title":"Effect of Intraoperative Dexamethasone on Post-op Dry Eye","status":"COMPLETED","sponsor":"SR Cornea Consultants","startDate":"2019-08-10","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT02416128","phase":"NA","title":"Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology","status":"WITHDRAWN","sponsor":"Larkin Community Hospital","startDate":"2015-04-30","conditions":"Iritis","enrollment":""},{"nctId":"NCT04380857","phase":"PHASE4","title":"Assessing Dextenza Insert After SMILE Procedure","status":"COMPLETED","sponsor":"William Wiley, MD","startDate":"2020-06-18","conditions":"Post Procedural Infection","enrollment":20},{"nctId":"NCT04521140","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2020-10-16","conditions":"Corneal Edema, Corneal Defect, Corneal Transplant","enrollment":36},{"nctId":"NCT04462523","phase":"PHASE4","title":"DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery","status":"COMPLETED","sponsor":"Patrick R. Oellers, MD","startDate":"2020-01-03","conditions":"Vitreo-Retinal Surgery","enrollment":40},{"nctId":"NCT04316936","phase":"PHASE4","title":"Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery","status":"COMPLETED","sponsor":"Silverstein Eye Centers","startDate":"2019-12-10","conditions":"Cataract Surgery","enrollment":15},{"nctId":"NCT04631315","phase":"PHASE4","title":"Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery.","status":"COMPLETED","sponsor":"Laboratorios Poen","startDate":"2019-03-24","conditions":"Cataract","enrollment":255},{"nctId":"NCT05665270","phase":"PHASE4","title":"A Study for Post op Inflammation After Cataract Surgery","status":"UNKNOWN","sponsor":"Wyse Eyecare","startDate":"2023-01-30","conditions":"Cataract","enrollment":40},{"nctId":"NCT02406209","phase":"PHASE2","title":"A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis","status":"COMPLETED","sponsor":"Aldeyra Therapeutics, Inc.","startDate":"2015-03","conditions":"Non-infectious Anterior Uveitis","enrollment":45},{"nctId":"NCT03320434","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2017-10-13","conditions":"Allergic Conjunctivitis","enrollment":120},{"nctId":"NCT05248139","phase":"NA","title":"Safety and Effectiveness of Drop-free Small Incision Cataract Surgery","status":"UNKNOWN","sponsor":"Visualiza","startDate":"2022-10","conditions":"Cataract, Ocular Inflammation, Ocular Hypertension","enrollment":100},{"nctId":"NCT03578276","phase":"PHASE4","title":"Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen","status":"COMPLETED","sponsor":"Carolina Eyecare Physicians, LLC","startDate":"2018-06-22","conditions":"Cataract","enrollment":35},{"nctId":"NCT05350384","phase":"","title":"An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2021-06-18","conditions":"Purtscher Retinopathy, Pancreatic Cancer","enrollment":1},{"nctId":"NCT04005079","phase":"PHASE3","title":"Pilocarpine After Combined Cataract/Trabectome Surgery","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2019-06-05","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":""},{"nctId":"NCT03626376","phase":"PHASE4","title":"Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2019-12-10","conditions":"Herpes Simplex Virus Keratitis","enrollment":""},{"nctId":"NCT04590183","phase":"NA","title":"The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome","status":"UNKNOWN","sponsor":"Peking University","startDate":"2020-10-01","conditions":"Posner Schlossman Syndrome","enrollment":30},{"nctId":"NCT01939691","phase":"PHASE4","title":"Macular Edema Nepafenac vs. Difluprednate Uveitis Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2018-09-12","conditions":"Uveitis, Macular Edema","enrollment":9},{"nctId":"NCT04705584","phase":"NA","title":"Topical Immuonosuppressant Drugs in Spring Catarrh","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-01","conditions":"Vernal Keratoconjunctivitis","enrollment":180},{"nctId":"NCT04273282","phase":"PHASE4","title":"A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%","status":"COMPLETED","sponsor":"Research Insight LLC","startDate":"2019-12-16","conditions":"Cataract","enrollment":31},{"nctId":"NCT00854061","phase":"PHASE3","title":"Study of T-PRED(TM) Compared to Pred Forte(R) II","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2009-02","conditions":"Cataract","enrollment":172},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT03596723","phase":"PHASE3","title":"KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children","status":"TERMINATED","sponsor":"Kala Pharmaceuticals, Inc.","startDate":"2018-07-03","conditions":"Ocular Inflammation","enrollment":2},{"nctId":"NCT00699803","phase":"PHASE2","title":"Study of T-PRED(TM) Compared to Pred Forte(R)","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2008-05","conditions":"Cataract","enrollment":64},{"nctId":"NCT04549935","phase":"PHASE4","title":"The PRIME Study: A Randomized, Controlled, Prospective Study","status":"RECRUITING","sponsor":"Vance Thompson Vision - MT","startDate":"2020-09-14","conditions":"Patient Preference, Patient Outcomes, Post-Operative Inflammation","enrollment":20},{"nctId":"NCT00689078","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2008-05","conditions":"Allergic Conjunctivitis","enrollment":36},{"nctId":"NCT04362241","phase":"PHASE4","title":"DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery","status":"UNKNOWN","sponsor":"Ophthalmic Consultants of the Capital Region","startDate":"2020-08-07","conditions":"Retinopathy, Diabetic","enrollment":30},{"nctId":"NCT04426734","phase":"PHASE4","title":"Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids","status":"UNKNOWN","sponsor":"New England Retina Associates","startDate":"2020-07-01","conditions":"Non-infectious Anterior Uveitis","enrollment":30},{"nctId":"NCT04281862","phase":"PHASE4","title":"DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery","status":"UNKNOWN","sponsor":"Vance Thompson Vision","startDate":"2020-01-23","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT03383328","phase":"PHASE4","title":"Study for Optimizing Anti-inflammatory Prophylaxis","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2018-02-01","conditions":"Postoperative Cystoid Macular Edema, Irvine-Gass Syndrome","enrollment":470},{"nctId":"NCT04205916","phase":"PHASE4","title":"A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery","status":"RECRUITING","sponsor":"Ophthalmic Consultants of Long Island","startDate":"2019-11-04","conditions":"Patient Preference","enrollment":50},{"nctId":"NCT03693989","phase":"PHASE3","title":"Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-10-04","conditions":"Cataract","enrollment":178},{"nctId":"NCT00981435","phase":"PHASE4","title":"Steroids After Laser Trabeculoplasty for Glaucoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Glaucoma","enrollment":97},{"nctId":"NCT01730872","phase":"PHASE4","title":"Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2012-11","conditions":"Chronic Allergic Conjunctivitis","enrollment":16},{"nctId":"NCT01475643","phase":"PHASE3","title":"Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-06","conditions":"Cataract","enrollment":107},{"nctId":"NCT01534195","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2012-01","conditions":"Allergic Conjunctivitis","enrollment":11},{"nctId":"NCT00493064","phase":"PHASE2, PHASE3","title":"To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions","status":"COMPLETED","sponsor":"Palo Alto Medical Foundation","startDate":"2006-10","conditions":"Retinal Vein Occlusion","enrollment":63},{"nctId":"NCT02547623","phase":"PHASE3","title":"Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery","status":"COMPLETED","sponsor":"ICON Bioscience Inc","startDate":"2015-11-06","conditions":"Cataract","enrollment":194},{"nctId":"NCT02517619","phase":"PHASE3","title":"Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis","status":"COMPLETED","sponsor":"Eyegate Pharmaceuticals, Inc.","startDate":"2016-01-16","conditions":"Anterior Uveitis","enrollment":251},{"nctId":"NCT01843920","phase":"NA","title":"The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble","status":"COMPLETED","sponsor":"Jason Hsu, MD","startDate":"2011-06","conditions":"Scleral Buckling","enrollment":21},{"nctId":"NCT01218737","phase":"PHASE3","title":"Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2009-01","conditions":"Ocular Infection and Inflammation","enrollment":101},{"nctId":"NCT02515045","phase":"PHASE4","title":"Dropless vs. Standard Drops Contralateral Eye Study","status":"COMPLETED","sponsor":"Carolina Eyecare Physicians, LLC","startDate":"2015-01","conditions":"Cataract","enrollment":59},{"nctId":"NCT01769352","phase":"PHASE2, PHASE3","title":"Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Post-surgical Cystoid Macular Edema (PSCME)","enrollment":42},{"nctId":"NCT01977781","phase":"PHASE1","title":"Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2013-12","conditions":"Ocular GVHD","enrollment":40},{"nctId":"NCT02309385","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis","status":"COMPLETED","sponsor":"Aciont Inc","startDate":"2014-10","conditions":"Non-Infectious Anterior Uveitis","enrollment":44},{"nctId":"NCT01673191","phase":"PHASE2","title":"A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus","status":"COMPLETED","sponsor":"Retinal Consultants of Arizona","startDate":"2012-11","conditions":"Macular Edema, Diabetes Mellitus","enrollment":40},{"nctId":"NCT00170729","phase":"PHASE4","title":"A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-08-17","conditions":"Cataract Surgery","enrollment":62},{"nctId":"NCT00478036","phase":"NA","title":"Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Open Angle Glaucoma","enrollment":31},{"nctId":"NCT01853072","phase":"PHASE3","title":"Nepafenac Once Daily for Macular Edema - Study 1","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-06","conditions":"Non-Proliferative Diabetic Retinopathy, Cataract","enrollment":881},{"nctId":"NCT01872611","phase":"PHASE3","title":"Nepafenac Once Daily for Macular Edema - Study 2","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-06","conditions":"Non-Proliferative Diabetic Retinopathy, Cataract","enrollment":819},{"nctId":"NCT01058278","phase":"NA","title":"Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2008-03","conditions":"Glaucoma, Inflammatory Response","enrollment":67},{"nctId":"NCT00485108","phase":"NA","title":"Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty","status":"COMPLETED","sponsor":"Queen's University","startDate":"2007-01","conditions":"Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma","enrollment":120},{"nctId":"NCT01853696","phase":"PHASE4","title":"Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty","status":"COMPLETED","sponsor":"Cornea Research Foundation of America","startDate":"2013-03","conditions":"Fuchs' Dystrophy, Corneal Edema","enrollment":167},{"nctId":"NCT01448213","phase":"PHASE2","title":"Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)","status":"COMPLETED","sponsor":"Price Vision Group","startDate":"2011-10","conditions":"Fuchs' Dystrophy, Bullous Keratopathy","enrollment":264},{"nctId":"NCT02028754","phase":"PHASE4","title":"A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-07","conditions":"Dry Eye Syndromes, Cataract","enrollment":180},{"nctId":"NCT01124045","phase":"PHASE3","title":"Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-08","conditions":"Cataracts, Inflammation","enrollment":80},{"nctId":"NCT01505088","phase":"PHASE3","title":"Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis","status":"COMPLETED","sponsor":"Eyegate Pharmaceuticals, Inc.","startDate":"2011-12","conditions":"Anterior Uveitis","enrollment":193},{"nctId":"NCT00198523","phase":"PHASE3","title":"A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2005-07","conditions":"Eye Infections, Postoperative Complications","enrollment":132},{"nctId":"NCT01201798","phase":"PHASE3","title":"Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-10","conditions":"Endogenous Anterior Uveitis","enrollment":111},{"nctId":"NCT00782717","phase":"PHASE2","title":"A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-11","conditions":"Macular Edema","enrollment":263},{"nctId":"NCT01244334","phase":"PHASE4","title":"Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.","status":"COMPLETED","sponsor":"Edward J. Holland","startDate":"2009-03","conditions":"Cataracts, Corneal Edema, Retinal Structural Change, Deposit and Degeneration","enrollment":52},{"nctId":"NCT00758199","phase":"PHASE4","title":"Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery","status":"COMPLETED","sponsor":"Bp Consulting, Inc","startDate":"2008-07","conditions":"Cataracts","enrollment":49},{"nctId":"NCT00833495","phase":"PHASE2","title":"Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation","status":"COMPLETED","sponsor":"Fovea Pharmaceuticals SA","startDate":"2009-01","conditions":"Allergic Conjunctivitis","enrollment":155},{"nctId":"NCT00744666","phase":"PHASE4","title":"IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids","status":"UNKNOWN","sponsor":"Hotel Dieu Hospital","startDate":"2008-09","conditions":"Vitreoretinal Disease, Ocular Hypertension","enrollment":70},{"nctId":"NCT00698724","phase":"PHASE4","title":"Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care","status":"COMPLETED","sponsor":"Bp Consulting, Inc","startDate":"2008-06","conditions":"Cataracts","enrollment":200},{"nctId":"NCT00469781","phase":"PHASE4","title":"Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening","status":"COMPLETED","sponsor":"Center For Excellence In Eye Care","startDate":"2007-05","conditions":"Cystoid Macular Edema,, Retinal Thickening","enrollment":95},{"nctId":"NCT00431028","phase":"PHASE1, PHASE2","title":"Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery","status":"TERMINATED","sponsor":"Federal University of São Paulo","startDate":"2005-09","conditions":"Inflammation, Bacterial Infections","enrollment":140},{"nctId":"NCT00134992","phase":"PHASE4","title":"A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-08","conditions":"Healthy","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DIZZINESS"},{"count":2,"reaction":"DRUG HYPERSENSITIVITY"},{"count":2,"reaction":"PAIN"},{"count":2,"reaction":"PNEUMONIA"},{"count":2,"reaction":"VISION BLURRED"},{"count":1,"reaction":"ABDOMINAL INJURY"},{"count":1,"reaction":"ACTIVITIES OF DAILY LIVING IMPAIRED"},{"count":1,"reaction":"AMNESIA"},{"count":1,"reaction":"ANAEMIA"},{"count":1,"reaction":"ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC"}],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Prednisolone acetate eye drops","genericName":"Prednisolone acetate eye drops","companyName":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","companyId":"shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prednisolone acetate is a corticosteroid that suppresses local inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene production. Used for Inflammation and pain following ocular surgery, Allergic conjunctivitis, Anterior uveitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}